Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mycobacterium genavense: an emerging pathogen

E C Böttger1

  • 1Institut für Medizinische Mikrobiologie, Medizinische Hochschule Hannover, Germany.

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|November 1, 1994
PubMed
Summary

Disseminated Mycobacterium genavense infection is a significant concern in AIDS patients, often mistaken for Mycobacterium avium complex due to similar symptoms and diagnostic challenges. Molecular methods are crucial for accurate identification and understanding its prevalence.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Revisiting susceptibility testing in MDR-TB by a standardized quantitative phenotypic assessment in a European multicentre study.

The Journal of antimicrobial chemotherapy·2015
Same author

Complement and the regulation of humoral immune responses.

Immunology today·2014
Same author

Transmission of multidrug-resistant tuberculosis in a low-incidence setting, Switzerland, 2006 to 2012.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2014
Same author

Evaluation of the AID TB resistance line probe assay for rapid detection of genetic alterations associated with drug resistance in Mycobacterium tuberculosis strains.

Journal of clinical microbiology·2014
Same author

The critical influence of the intermediate category on interpretation errors in revised EUCAST and CLSI antimicrobial susceptibility testing guidelines.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2012
Same author

Mycobacterium tuberculosis population structure determines the outcome of genetics-based second-line drug resistance testing.

Antimicrobial agents and chemotherapy·2012

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Immunology

Background:

  • Disseminated mycobacterial infections are common in patients with Acquired Immunodeficiency Syndrome (AIDS).
  • Mycobacterium avium complex (MAC) is a frequent cause of such infections.
  • A newly identified species, Mycobacterium genavense, has also been isolated from AIDS patients.

Observation:

  • Mycobacterium genavense exhibits fastidious growth requirements, leading to poor and variable in vitro growth.
  • Standard culture-based diagnostic techniques face challenges in detecting and identifying Mycobacterium genavense.
  • Clinical manifestations of Mycobacterium genavense infections mimic those of MAC infections.

Findings:

  • Molecular biology techniques are essential for the accurate diagnosis of Mycobacterium genavense infections.

Related Experiment Videos

  • These molecular methods have confirmed Mycobacterium genavense as a cause of disseminated infection in immunosuppressed individuals.
  • The similarity in clinical presentation between Mycobacterium genavense and MAC infections likely leads to underestimation of Mycobacterium genavense prevalence.

    • Implications:

    • Accurate diagnosis and identification of Mycobacterium genavense are critical for effective patient management in immunocompromised populations.
    • The reliance on traditional culture methods may obscure the true incidence of Mycobacterium genavense infections.
    • Further research utilizing molecular diagnostics is needed to ascertain the actual prevalence and clinical impact of Mycobacterium genavense in AIDS patients.